Publication

Byline

Location

Lilly's Retatrutide Delivered Significant Weight Loss, A1C Reduction In Phase 3 Trial

India, Sept. 30 -- Eli Lilly and Company (LLY) reported detailed Phase 3 TRIUMPH-2 results showing that Retatrutide delivered substantial weight loss and blood sugar reductions in adults with obesity ... और पढ़ें


Vanda Reports Positive Phase 3 Results For HETLIOZ In Delayed Sleep-Wake Phase Disorder; Stock Up

India, Sept. 30 -- Vanda Pharmaceuticals Inc. (VNDA) announced positive topline results from its pivotal Phase 3 study of HETLIOZ (tasimelteon) in adults with Delayed Sleep-Wake Phase Disorder, a circ... और पढ़ें


Bret Michaels Announces First New Shows Since Health Scare

India, Sept. 29 -- Poison frontman Bret Michaels has announced five new shows, marking his return to live performances after postponing his 2026 tour following emergency surgery for a kidney stone. M... और पढ़ें


Veracyte's Decipher Test Predicts Hormone Therapy Benefit In Phase 3 Prostate Cancer Analysis

India, Sept. 29 -- On Tuesday, Veracyte (VCYT) announced new findings from a retrospective analysis of the Phase 3 NRG/RTOG 0815 trial showing that its Decipher Prostate Genomic Classifier can identif... और पढ़ें


Vesuvius Board Is In Talks With RHI Magnesita About Revised Takeover Proposal, Stock Rises

India, Sept. 29 -- Tuesday, RHI Magnesita N.V. (RHIM.L) announced that it is in advanced discussions with the board of Vesuvius plc (VSVS.L) regarding a possible recommended cash-and-stock deal. The p... और पढ़ें


Lilly: Zepbound Shows Greater Weight Loss Than Wegovy HD In New Analysis

India, Sept. 29 -- Eli Lilly (LLY) said a new analysis found that people taking Zepbound 15 mg lost an average of 4.5% more body weight than those taking Wegovy HD at 72 weeks. The comparison was base... और पढ़ें


Moleculin Completes Part A Enrollment In Phase 2/3 MIRACLE Trial For Relapsed AML

India, Sept. 29 -- Moleculin Biotech (MBRX) has completed enrolment in Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) in adults with relaps... और पढ़ें


U.S. Stocks Lack Direction Ahead Of Key Inflation Data

India, Sept. 29 -- Following the weakness seen in the previous session, stocks have shown a lack of direction over the course of the trading day on Tuesday. The major averages have spent the day bounc... और पढ़ें


Court Sanctions Nuveen's Recommended Cash Bid For Schroders

India, Sept. 29 -- Tuesday, American asset manager Nuveen LLC announced that the Court has sanctioned the Scheme of Arrangement for the recommended cash acquisition of Schroders plc (SDR.L) by Bidco, ... और पढ़ें


Ernexa Selected For Emerging Track At 2026 Cell & Gene Meeting On The Mesa

India, Sept. 29 -- Tuesday, Ernexa Therapeutics (ERNA) said it has been selected for the Emerging Track at the 2026 Cell & Gene Meeting on the Mesa, where CEO Sanjeev Luther will present the company's... और पढ़ें